🇺🇸 FDA
Patent

US 8685929

Detecting CYP24 expression level as a marker for predisposition to cancer

granted A61PA61P35/00A61P35/04

Quick answer

US patent 8685929 (Detecting CYP24 expression level as a marker for predisposition to cancer) held by The Regents of the University of California expires Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 01 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61P, A61P35/00, A61P35/04